PRAZOSIN HYDROCHLORIDE Drug Patent Profile
✉ Email this page to a colleague
When do Prazosin Hydrochloride patents expire, and what generic alternatives are available?
Prazosin Hydrochloride is a drug marketed by Alembic, Am Therap, Ani Pharms, Appco, Aurobindo Pharma Ltd, Dava Pharms Inc, Granules, Lannett Co Inc, Mankind Pharma, MSN, Mylan, Novitium Pharma, Purepac Pharm, Teva Pharms, and Watson Labs. and is included in twenty-three NDAs.
The generic ingredient in PRAZOSIN HYDROCHLORIDE is prazosin hydrochloride. There are seventeen drug master file entries for this compound. Thirty suppliers are listed for this compound. Additional details are available on the prazosin hydrochloride profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Prazosin Hydrochloride
A generic version of PRAZOSIN HYDROCHLORIDE was approved as prazosin hydrochloride by TEVA PHARMS on September 12th, 1988.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for PRAZOSIN HYDROCHLORIDE?
- What are the global sales for PRAZOSIN HYDROCHLORIDE?
- What is Average Wholesale Price for PRAZOSIN HYDROCHLORIDE?
Summary for PRAZOSIN HYDROCHLORIDE
| US Patents: | 0 |
| Applicants: | 15 |
| NDAs: | 23 |
| Finished Product Suppliers / Packagers: | 28 |
| Raw Ingredient (Bulk) Api Vendors: | 117 |
| Clinical Trials: | 67 |
| Patent Applications: | 1,782 |
| What excipients (inactive ingredients) are in PRAZOSIN HYDROCHLORIDE? | PRAZOSIN HYDROCHLORIDE excipients list |
| DailyMed Link: | PRAZOSIN HYDROCHLORIDE at DailyMed |
Recent Clinical Trials for PRAZOSIN HYDROCHLORIDE
Identify potential brand extensions & 505(b)(2) entrants
| Sponsor | Phase |
|---|---|
| Kinnov Therapeutics | Phase 1 |
| The Royal's Institute of Mental Health Research | Early Phase 1 |
| Ottawa Hospital Research Institute | Early Phase 1 |
Pharmacology for PRAZOSIN HYDROCHLORIDE
| Drug Class | alpha-Adrenergic Blocker |
| Mechanism of Action | Adrenergic alpha-Antagonists |
Medical Subject Heading (MeSH) Categories for PRAZOSIN HYDROCHLORIDE
Anatomical Therapeutic Chemical (ATC) Classes for PRAZOSIN HYDROCHLORIDE
US Patents and Regulatory Information for PRAZOSIN HYDROCHLORIDE
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Teva Pharms | PRAZOSIN HYDROCHLORIDE | prazosin hydrochloride | CAPSULE;ORAL | 071745-003 | Sep 12, 1988 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
| Mylan | PRAZOSIN HYDROCHLORIDE | prazosin hydrochloride | CAPSULE;ORAL | 072575-002 | May 16, 1989 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
| Watson Labs | PRAZOSIN HYDROCHLORIDE | prazosin hydrochloride | CAPSULE;ORAL | 072609-001 | May 16, 1989 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
